Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
Neurological perspectives on voltage-gated sodium channels.
Vitamin D in autoimmune liver disease.
Mortality in patients with multiple sclerosis.
Prevalence of neurological conditions across the continuum of care based on interRAI assessments.
T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression.
Urinary tract infections in multiple sclerosis.
The effect of rhythmic-cued motor imagery on walking, fatigue and quality of life in people with multiple sclerosis: A randomised controlled trial.
Type D, anxiety and depression in association with quality of life in patients with Parkinson's disease and patients with multiple sclerosis.
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
Iron oxide magnetic nanoparticles highlight early involvement of the choroid plexus in central nervous system inflammation.
[Effect of therapeutic apheresis on the lymphocyte sensitivity to corticosteroids in patients with secondary progressive multiple sclerosis.]
[Optic neuritis--immunological approach to elucidate pathogenesis and develop innovative therapy].
Do Flexible Goal Adjustment and Acceptance Help Preserve Quality of Life in Patients with Multiple Sclerosis?
Neurologic indications for therapeutic plasma exchange: 2013 update.
Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey.
Low levels of vitamin d in neuromyelitis optica spectrum disorder: association with disease disability.
Fitness and cognitive processing speed in persons with multiple sclerosis: A cross-sectional investigation.
Relationship between urodynamic findings and sexual function in multiple sclerosis patients with lower urinary tract dysfunction.
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.
Managing psychological stress in the multiple sclerosis medical visit: Patient perspectives and unmet needs.
Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.
High-Content Phenotypic Screening and Triaging Strategy to Identify Small Molecules Driving Oligodendrocyte Progenitor Cell Differentiation.
Quantitative Measurement of tissue damage and recovery within new T2w lesions in pediatric- and adult-onset multiple sclerosis.
Technical developments of functional electrical stimulation to correct drop foot: Sensing, actuation and control strategies.
Pages
« first
‹ previous
…
478
479
480
481
482
483
484
485
486
…
next ›
last »